Coursework and Project Assessment Notes

Project Focus

• Title: "In silico Design of Novel Flavonoids Targeting ATP Binding Site of CDK6 for Potential Glioblastoma Treatment."

• Abstract: Focus on designing flavonoid-based inhibitors for glioblastoma using molecular docking.

Glioblastoma Overview

• GBM has very poor survival rates and therapeutic challenges like BBB permeability.

• Standard treatments include surgical resection and TMZ administration, but outcome remains unfavorable.

CDK6 Inhibition Strategy

• CDK4/6 promotes cell cycle progression. Inhibiting CDK6 can halt cancer growth.

• Discuss FDA-approved inhibitors and their limitations regarding BBB penetration and side effects.

Methodology

• Use molecular docking for evaluating flavonoid derivatives against CDK6.

• Primary focus on binding affinities and pharmacokinetic properties.

Results Overview

• Highlighted top compounds with strong predicted binding affinities.

• Conduct ADMET analysis for evaluating the drug-likeness of compounds.

Key Findings

• Examples of flavonoids include fisetin and quercetin showing varying CDK6 inhibition potential.

• Emphasize the implications of binding interactions and structural modifications on compound efficacy.

Future Directions

• Need MD simulations and experimental validation of predicted interactions and biological behavior.

• In vitro and in vivo tests are essential before clinical application.

Conclusion

• Highlight successful design of flavonoid inhibitors targeting CDK6, suggesting potential effectiveness against GBM, but underscore the need for further testing.